Volume 18 - Issue 1 - January 2005

Diabetes Watch »

When Wounds Require Multidisciplinary Care

By Eric H. Espensen, DPM | 10034 reads | 0 comments

   Management of the diabetic foot is a tremendous challenge. It has been estimated that the annual healthcare costs of caring for the diabetic foot range in the billions.1 Approximately 15 percent of diabetic patients will develop a foot or leg ulceration at some point during the course of their disease and 50 percent of those patients suffer reulceration within 18 months.2 Researchers have observed that the prevalence of neuropathy in the diabetic population is 33.5 percent, the prevalence of vascular disease is 12.7 percent and the prevalence of foot ulc



Diagnostic Dilemmas »

How To Diagnose And Treat Interdigital Neuritis

By David Soomekh, DPM, and Babak Baravarian, DPM | 30873 reads | 0 comments

   In 1876, Morton described a peculiar and painful affliction of the foot in the area of the fourth and fifth metatarsals as the metatarsals compress the plantar interdigital nerve. Describing this as a neuroma is bit of a misnomer as the condition is more likely an entrapment rather than a true neuroma. The effects of compression on nerve fibers are extensive. Nerve compression can be from external edema surrounding the nerve, edema within the nerve or external compression from other anatomical structures in the area.

   It may be more appropriate to refer t



News and Trends »

New Study Cites Benefits Of Ertapenem For Diabetic Foot Infections

By Brian McCurdy, Associate Editor | 5220 reads | 0 comments

   In the past, the majority of comparative studies of antibiotics for diabetic foot infections have been relegated to smaller, unblinded trials. However, a new randomized, multicenter study of over 500 patients found that the simpler dosing regimen of ertapenem (Invanz, Merck) had comparable results to piperacillin/tazobactam in treating these infections.

   In what study co-author David G. Armstrong, DPM, MSc, PhD, calls “easily the largest ever randomized controlled trial of diabetic foot infections,” the double-blinded SIDESTEP Study of Diabetic Foot I



Wound Care Q&A »

Exploring The Potential Of Growth Factors In Chronic Wounds

Clinical Editor: Lawrence Karlock, DPM | 6347 reads | 0 comments

   Do growth factors improve the rate of wound healing? When is it appropriate to use them on chronic wounds? Is the cost of growth factor modalities worth the results? Our expert panelists answer these key questions, share their experiences and ponder the future of these modalities with their discussion about the efficacy of growth factors in chronic wound care. Without further delay, here is what they had to say …

   Q: When, why and how do you utilize growth factors in the treatment of foot and ankle wounds?

   A: Wound bed prepar



Feature »

A Closer Look At Bone Graft Substitutes

By D. Scot Malay, DPM | 25106 reads | 0 comments

   There are many instances when it is appropriate for the foot and ankle surgeon to use bone grafts in order to enhance a patient’s clinical outcome. When it comes to reconstructive osteotomies for angular realignment, arthrodeses and the repair of nonunions and cystic bone lesions, these are often best performed with procedures that take advantage of the many desirable features of bone grafts and, more recently, bone graft substitutes.

   Before discussing the details of bone graft substitutes, it is helpful to review the bone graft options that are availa